Biocon receives Health Canada approval for Bosaya and Vevzuo biosimilars to Prolia and Xgeva
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
Angelique Kruif brings over 20 years of HR leadership built across a range of international organisations
The move reinforces Croda’s push to fuel growth through high-impact innovation across its Consumer Care portfolio
Sanplatec is leading the industry in the field of containers and devices for cell culture and live transport
Targets high-growth eye care expansion push
In his new role, Curtis will lead the formulation and execution of the company’s global technical strategy
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
PMDA is regarded among the most stringent regulatory bodies globally
The innovation is particularly suited for bone and cartilage repair
Subscribe To Our Newsletter & Stay Updated